Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Subjects With Impaired Renal Function and Healthy Subjects”

Showing 20 of 0 results

Early research (Phase 1)Study completedNCT01309438
What this trial is testing

Erythromycin and Rivaroxaban in Study Participants With Normal and Reduced Kidney Function

Who this might be right for
HealthyRenal Insufficiency
Janssen Research & Development, LLC 29
Early research (Phase 1)Study completedNCT04056455
What this trial is testing

Mobocertinib Capsules in People With Severe Kidney Problems and People With Healthy Kidneys

Who this might be right for
Renal ImpairmentHealthy Volunteers
Millennium Pharmaceuticals, Inc. 26
Early research (Phase 1)Study completedNCT05368935
What this trial is testing

Nitazoxanide Pharmacokinetic Parameters in Renal Impaired Subjects

Who this might be right for
Renal ImpairmentRenal DiseaseKidney Disease
Genfit 77
Early research (Phase 1)Study completedNCT01578928
What this trial is testing

A Phase l Study to Evaluate the Pharmacokinetics and Safety Pasireotide in Subjects With Varying Degrees of Renal Impairment Compared to Healthy Volunteers

Who this might be right for
Renal Impairment
Novartis Pharmaceuticals 50
Early research (Phase 1)Study completedNCT01459250
What this trial is testing

Pharmacokinetics, Safety and Tolerability of AGO178C in Subjects With Renal Deficiencies Compared With Healthy Subjects

Who this might be right for
Renal Impairment
Novartis Pharmaceuticals 32
Early research (Phase 1)Study completedNCT02254070
What this trial is testing

Influence of Different Degrees of Renal Impairment on the Safety, Tolerability, Pharmacodynamics and Pharmacokinetics of BIBT 986 BS in Subjects With Normal Renal Function and Patients With Different Degrees of Renal Impairment

Who this might be right for
Healthy
Boehringer Ingelheim 23
Not applicableStudy completedNCT02087566
What this trial is testing

Linezolid Pharmacokinetics In Patients With Impaired Renal Function (PPT6)

Who this might be right for
Renal FailureImpaired Renal Function
Damanhour University 18
Testing effectiveness (Phase 2)Ended earlyNCT00787618
What this trial is testing

Evaluate PK and Safety of Proellex® in Females With Various Stages of Impaired Renal Function and Healthy Females

Who this might be right for
Renal Impairment
Repros Therapeutics Inc. 6
Early research (Phase 1)Study completedNCT01759576
What this trial is testing

Assess the Pharmacokinetics, Pharmacodynamics, and Safety of Canagliflozin (JNJ-28431754) in Volunteers With Varying Degrees of Kidney Function

Who this might be right for
Renal InsufficiencyHealthy
Johnson & Johnson Pharmaceutical Research & Development, L.L.C. 40
Early research (Phase 1)Study completedNCT02135276
What this trial is testing

A Phase 1, Open-Label Study to Assess the Single-Dose Pharmacokinetics of Eravacycline in Subjects With End Stage Renal Disease and Healthy Subjects

Who this might be right for
End Stage Renal Disease
Tetraphase Pharmaceuticals, Inc 12
Early research (Phase 1)Study completedNCT06911320
What this trial is testing

Study of Bemnifosbuvir/Ruzasvir as a Fixed-dose Combination in Subjects With Normal or Severely Impaired Renal or Hepatic Function

Who this might be right for
Healthy Volunteer StudyHepatic ImpairmentRenal Impairment
Atea Pharmaceuticals, Inc. 28
Not applicableEnded earlyNCT02196610
What this trial is testing

Feasibility Study of Arterial Stiffness in Hemodialysis Patients

Who this might be right for
End-Stage Renal Disease
Ottawa Hospital Research Institute 36
Early research (Phase 1)Study completedNCT02022748
What this trial is testing

Pharmacokinetics, Pharmacodynamics, and Safety Study of Ticagrelor in Hemodialysis Patients and Healthy Subjects

Who this might be right for
Kidney Failure, Chronic
AstraZeneca 27
Early research (Phase 1)Study completedNCT02312973
What this trial is testing

To Investigate Pharmacokinetics (Absorption, Distribution, Elimination), Safety and Tolerability of a Single Oral Dose of 75 mg Molidustat Tablet in Male and Female Subjects Requiring Hemo- or Peritoneal Dialysis Compared to Healthy Subjects

Who this might be right for
Renal Insufficiency, Chronic
Bayer 40
Early research (Phase 1)Study completedNCT04722484
What this trial is testing

A Trial to Learn How Safe Vericiguat (BAY1021189) is and the Way the Body Absorbs, Distributes and Gets Rid of Vericiguat in Participants With Kidney Disease and in Age-, Weight- and Gender-matched Healthy Participants

Who this might be right for
Heart Failure
Bayer 39
Early research (Phase 1)Study completedNCT03289208
What this trial is testing

Pharmacokinetics Study of MCI-186 in Subjects With Mild or Moderate Renal Impairment

Who this might be right for
Renal ImpairmentHealthy
Shionogi 30
Early research (Phase 1)Study completedNCT04510090
What this trial is testing

Evaluate the Safety, Tolerability, and PK of EP547 in Healthy Subjects and Subjects With Cholestatic or Uremic Pruritus

Who this might be right for
PruritusCholestasisKidney Failure
Escient Pharmaceuticals, Inc 89
Early research (Phase 1)Study completedNCT02040597
What this trial is testing

Investigate the Pharmacokinetics, Safety and Tolerability of CHF 5993 pMDI in Subjects With Renal Impairment.

Who this might be right for
Chronic Obstructive Pulmonary Disease (COPD)
Chiesi Farmaceutici S.p.A. 42
Early research (Phase 1)Study completedNCT01028768
What this trial is testing

Pharmacokinetics of 10 mg Teduglutide in Subjects With Renal Impairment Compared to Healthy Subjects With Normal Renal Function

Who this might be right for
Renal Impairment
Nycomed 36
Early research (Phase 1)Study completedNCT02354937
What this trial is testing

Pharmacokinetics Study of GSK1265744 in Subjects With Severe Renal Impairment

Who this might be right for
Infection, Human Immunodeficiency VirusHIV Infections
ViiV Healthcare 16
Next Page

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation